ERAS in Choledochal Cyst & Biliary Atresia
Early Oral Feeding Versus Conventional Feeding After Surgery for Biliary Atresia and Choledochal Cyst: A Randomized Controlled Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
This study aims to compare two feeding approaches after surgery for biliary atresia and choledochal cyst in children. Traditionally, children are kept without oral feeding for more than 48 hours after these operations until bowel activity returns. However, newer Enhanced Recovery After Surgery (ERAS) programs suggest that starting feeding earlier may help children recover faster. In this study, children undergoing surgery for biliary atresia or choledochal cyst will be randomly assigned to one of two groups. One group will start oral liquids within 24 hours after surgery and gradually progress to normal feeding as tolerated (early feeding group). The other group will receive conventional care, where feeding is started after more than 48 hours once bowel activity has returned. Researchers will compare both groups for postoperative complications such as wound infection and anastomotic leakage, as well as the duration of hospital stay. Additional observations will include vomiting, abdominal distension, need for reinsertion of a nasogastric tube, requirement for repeat surgery, and time taken to resume normal feeding. Participation in the study will not affect the standard surgical treatment provided. All children will receive routine perioperative care and will be monitored closely throughout their hospital stay and follow-up visits. The findings of this study may help determine whether early oral feeding is a safe and effective strategy to improve recovery and reduce hospitalization after pediatric hepatobiliary surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 27, 2024
CompletedFirst Submitted
Initial submission to the registry
June 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 16, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedJuly 16, 2026
July 1, 2026
1.9 years
June 13, 2026
July 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Wound Infection
Condition characterized with presence of redness, swelling, warmth, pain or purulent discharge from surgical site classified according to CDC SSI grading.
Within 04 weeks of surgery
Anastomotic Leak
When surgical anastomosis fails and there is leakage proven with signs of peritonitis on clinical examination, pneumoperitoneum on radiographs
Within hospital stay or on readmission within 1 month
Length of Hospital Stay
Duration of stay measured in days
From the date of surgery until the date of hospital discharge, assessed up to 30 days
Secondary Outcomes (3)
Vomiting
From start of feeding till 30 days post-operatively
Abdominal Distension
from initiation of oral feeds till 30 days post-operatively
Need for Re-operation
From start of oral feeds till 04 weeks post-op
Study Arms (4)
ERAS Feeding Protocol in Choledochal Cyst
EXPERIMENTALThe patients with Roux-en-Y hepaticojejunostomy for choledochal cyst will be started oral liquids within 24 hours of surgery, NG Tube will be removed before starting oral feeds
Conventional Feeding Protocol in Choledochal Cyst
ACTIVE COMPARATORThe post operative patients of Roux-en-Y hepaticojejunostomy for choledochal cyst will be allowed oral liquids after confirmation of resumption of bowel function (Positive bowel sounds, passage of stool or flatus, clear NG aspirate)
ERAS in Biliary Atresia
EXPERIMENTALPost-op patients of Roux-en-Y portoenterostomy for biliary atresia will be allowed oral liquids within 24 hours of surgery and NG tube will be removed.
Conventional feeding protocol in Biliary Atresia
ACTIVE COMPARATORPost-op patients of portoenterostomy for biliary atresia will be allowed oral feeds only after confirmation of bowel functions (positive bowel sounds, passage of stool or flatus, clearing of NG aspirate)
Interventions
In ERAS feeding protocol or early oral feeding protocol, patients will be allowed oral liquids within 24 hours of surgery irrespective of confirmation of bowel functions.
In conventional feeding protocol, feeds will be resumed after surgery on confirmation of bowel functions with auscultation for bowel sounds or passage of stool or flatus, usually after 48 hours
Eligibility Criteria
You may qualify if:
- All children diagnosed with choledochal cyst type I and IV on MRCP or CT scan, undergoing elective Roux-En-Y hepaticojejunostomy
- All children with provisional diagnosis of biliary atresia undergoing Roux-En-Y portoenterostomy
You may not qualify if:
- Patients with suspected biliary atresia not undergoing portoenterostomy after Per-op cholangiogram either due to ruling out of disease or advanced disease deemed candidates for liver transplant
- patients with history of Emergency surgery or external drainage of choledochal cyst
- Hemodynamically unstable patients after surgery
- Previous history of GI surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Child Health Sciences, The Children's Hospital, Lahore
Lahore, Punjab Province, 54300, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sundas Zahra, MBBS
University of Child Health sciences & The Children's Hospital, Lahore
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
June 13, 2026
First Posted
July 16, 2026
Study Start
July 27, 2024
Primary Completion
July 1, 2026
Study Completion
August 1, 2026
Last Updated
July 16, 2026
Record last verified: 2026-07